Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis

Chemical Research in Toxicology

Volumn 9, Issue 7, 1996, Pages 1159-1166

  Bourdi, Mohammed ^a   Chen, Weiqiao ^b   Peter, Raimund M ^b   Martin, Jackie L ^c   Buters, Jeroen T M ^d   Nelson, Sidney D ^b   Pohl, Lance R ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOCHROME P450; DESFLURANE; ENFLURANE; HALOTHANE; ISOFLURANE;

ACETYLATION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEPATITIS; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY;

ACETYLATION; AUTOANTIBODIES; AUTOANTIGENS; CYTOCHROME P-450 CYP2E1; FLUORINE; HALOTHANE; HEPATITIS, TOXIC; HUMANS;

UNIDENTIFIED BACULOVIRUS;

EID: 0029909785     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960083q     Document Type: Article

References (57)

1. Pohl, L. R. (1990) Drug-induced allergic hepatitis. Semin. Liver Dis. 10, 305-315.
2. Kenna, J. G. (1991) The molecular basis of halothane-induced hepatitis. Biochem. Soc. Trans. 19, 191-195.
3. Martin, J. L., Plevak, D. J., Flannery, K. D., Chariten, M., Poterucha, J. J., Humphreys, C. E., Derfus, G., and Pohl, L. R. (1995) Hepatotoxicity after desflurane anesthesia, Anesthesiohgy 83 (5), 1125-1129.
4. Thomassen, D., Martin, B. M., Martin, J. L., Pumford, N. R., and Pohl, L. R. (1990) The role of a stress protein in the development of a drug-induced allergic response. Eur. J. Pharmacol. 183, 1138-1139.
5. Davila, J. C., Martin, B. M., and Pohl, L. R. (1992) Patients with halothane hepatitis have serum antibodies directed against glucose-regulated stress protein GRP78/BiP. Toxicologist 12, 255.
6. Pumford, N. R., Martin, B. M., Thomassen, D., Burris, J. A., Kenna, J. G., Martin, J. L., and Pohl, L. R. (1993) Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72. Chem. Res. Toxicol. 6, 609-615.
7. Butler, L. E., Thomassen, D., Martin, J. L., Martin, B. M., Kenna, J. G., and Pohl, L. R. (1992) The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane. Chem. Res. Toxicol. 5, 406-410.
8. Satoh, H., Martin, B. M., Schulick, A. H., Christ, D. D., Kenna, J. G., and Pohl, L. R. (1989) Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc. Natl. Acad. Sci. U.S.A. 86, 322-326.
9. Bourdi, M., Demady, D., Martin, J. L., Jabbour, S., Martin, B., George, J., and Pohl, L. R. (1995) cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58: characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase. Arch. Biochem. Biophys. 323, 397-403.
10. Martin, J. L., Kenna, J. G., Martin, B. M., Thomassen, D., Reed, G. F., and Pohl, L. R. (1993) Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase. Hepatology 18, 858-863.
11. Pohl, L. R., Kenna, J. G., Satoh, H., Christ, D., and Martin, J. L. (1989) Neoantigens associated with halothane hepatitis. Drug. Metab. Rev. 20, 203-217.
12. Martin, J. L., Reed, G. F., and Pohl, L. R. (1993) Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis. Biochem. Pharmacol. 46, 1247-1250.
13. Smith, G. C. M., Kenna, J. G., Harrison, D., Tew, D., and Wolf, C. R. (1993) Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. Lancet 342, 963-964.
14. Frey, N., Christen, U., Jeno, P., Yeaman, S. J., Shimomura, Y., Kenna, J. G., Gandolfi, A. J., Ranek, L., and Gut, J. (1995) The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis. Chem. Res. Toxicol. 8, 736-746.
15. Kitteringham, N. R., Kenna, J. G., and Park, B. K. (1995) Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis. Br. J. Clin. Pharmacol. 40, 379-386.
16. Kharasch, E. D., Hankins, D., Mautz, D., and Thummel, K. E. (1996) Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet 347, 1367-1371.
17. Peter, R., Bocker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C. S. (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem. Res. Toxicol. 3, 566-573.
18. Satoh, H., Fukuda, Y., Anderson, D. K., Ferrans, V. J., Gillette, J. R., and Pohl, L. R. (1985) Immunological studies on the mechanism of halothane-induced hepatotoxicity: Immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmacol. Exp. Ther. 233, 857-862.
19. Buters, J. T. M., Korzekwa, K. R., Kunze, K. L., Omata, Y., Hardwick, J. P., and Gonzalez, F. J. (1994) cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug. Metab. Dispos. 22, 688-692.
20. Shen, A. L., Porter, T. D., Wilson, T. E., and Kasper, C. B. (1989) Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 264, 7584-7589.
21. Holsman, P. L., Shet, M. S., Martin-Wixtrom, C. A., Fisher, C. W., and Estabrook, R. W. (1994) The high level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome 65 and studies on their mechanism of function. Arch. Biochem. Biophys. 312, 554-565.
22. Kling, L., Legroen, W., and Netter, K. J. (1985) Induction of liver cytochrome P-450 in mice by warfarin. Biochem. Pharmacol. 34, 85-91.
23. Yang, M. X., and Cederbaum, A. I. (1994) Fractionation of liver microsomes with polyethylene glycol and purification of NADP-cytochrome is oxidoreductase and cytochrome 65. Arch. Biochem. Biophys. 315, 438-444.
24. Thummel, K. E., Kharasch, E. D., Podoll, T., and Kunze, K. (1993) Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug. Metab. Dispos. 21, 350-357.
25. Kenna, J. G., Neuberger, J., and Williams, R. (1987) Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis. Br. J. Anaesth. 59, 1286-1290.
26. Martin, J. L., Kenna, J. G., and Pohl, L. R. (1990) Antibody assays for the detection of patients sensitized to halothane. Anesth. Analg. 70, 154-159.
27. Amouzedeh, H., and Pohl, L. R. (1995) Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes. Hepatology 22, 936-943.
28. Gonzalez, F. J., Schmid, B. J., Umeno, M., McBride, O. W., Hardwick, J. P., Meyer, U. A., Gelboin, H. V., and Idle, J. R. (1988) Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 7, 79-86.
29. Beaune, P. H., Pessayre, D., Dansette, P., Mansuy, D., and Manns, M. (1994) Autoantibodies against cytochrome P450: role in human diseases. Adv. Pharmacol. 40, 199-245.
30. Zanger, U. M., Hauri, H., Loeper, J., Homberg, J. C., and Meyer, U. A. (1988) Antibodies against human cytochrome P450 dbl in autoimmune hepatitis type II. Proc. Natl. Acad. Sci. U.S.A. 85, 8256-8260.
31. Manns, M. P., Griffin, K. J., Quattrochi, L. C., Sacher, M., Thaler, H., Tukey, R. H., and Johnson, E. F. (1990) Identification of cytochrome P450 1A2 as a human autoantigen. Arch. Biochem. Biophy. 280, 229-232.
32. Bednarek, J., Furmaniak, J., Wedlock, N., Kiso, Y., Baumann-Antczak, F., Krishnan, H., Craft, J. A., and Rees Smith, B. (1992) Steroid-21-hydroxylase is a major autoantigen involved in adult-onset autoimmune Addison's disease. FEBS Lett. 309, 51-55.
33. Uibo, R., Aavik, E., Peterson, P., Perheentupa, J., Aranko, S., Pelkonen, R., and Krohn, K. J. (1994) Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J. Clin. Endocrinol. Metab. 78, 323-328.
34. Beaune, P. H., Dansette, P. M., Mansuy, D., Riffel, L., Finck, M., Amar, C., Leroux, J. P., and Homberg, J. C. (1987) Human antiendoplasmic reticulum autoantibodies appearing in a drug induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc. Natl. Acad. Sci. U.S.A. 84, 551-555.
35. Bourdi, M., Larrey, D., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F. P., and Beaune, P. H. (1990) Antiliver endoplasmic reticulum autoantibodies are directed against human cytochrome P450 1A2: A specific marker of dihydralazine-induced hepatitis. J. Clin. Invest. 85, 1967-1973.
36. Duclos-Vallee, J. C., Hajoui, O., Yamamoto, A. M., Jacz-Aigrain, E., and Alvarez, F. (1995) Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies. Gastroenterology 108, 470-476.
37. Leung, P. S., Chuang, D. T., Wynn, R. M., Cha, S., Danner, D. J., Ansari, A., Coppel, R. L., and Gershwin, M. E. (1995) Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 22, 505-513.
38. Tuomi, T., Rowley, M. J., Knowles, W. J., Chen, Q. Y., McAnally, T., Zimmet, P. Z., and Mackay, I. R. (1994) Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin. Immunol. Immunopathol. 71, 53-59.
39. Gueguen, M., Boniface, O., Bernard, O., Clerc, F., Cartwright, T., and Alvarez, F. (1991) Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody. J. Autoimmun. 4, 607-615.
40. Baum, H., Butler, P., Davies, H., Sternberg, M. J., and Burroughs, A. K. (1993) Autoimmune disease and molecular mimicry: an hypothesis. Trends Biochem. Sci. 18, 140-144.
41. Hodgkin, P. D., and Basten, A. (1995) B cell activation, tolerance and antigen-presenting function. Curr. Opin. Immunol. 7, 121-129.
42. Haba, S., and Nisonoff, A. (1992) IgE-secreting cells in the thymus: correlation with induction of tolerance to IgE. Proc. Natl. Acad. Sci. U.S.A. 89, 5185-5187.
43. Adelstein, S., Pritchard-Briscoe, H., Anderson, T. A., Crosbie, J., Gammon, G., Loblay, R. H., Basten, A., and Goodnow, C. C. (1991) Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science 251, 1223-1225.
44. Weigle, W. O. (1964) The induction of autoimmunity in rabbits following injection of heterologous or altered homologous thyroglobulin. J. Exp. Med. 121, 289-307.
45. Deodhar, S. D., Haas, E., and Goldblatt, H. (1964) Production of antirenin to homologous renin and its effect on experimental renal hypertension. J. Exp. Med. 119, 425-432.
46. Haba, S., and Nisonoff, A. (1987) Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE. Proc. Natl. Acad. Sci. U.S.A. 84, 5009-5013.
47. Allison, A. C. (1989) Theories of self tolerance and autoimmunity. In Autoimmunity and Toxicology (Kammuller, M. E., Bloksma, N., and Seinen, W., Eds.) pp 67-115, Elsevier, New York.
48. Steinhoff, U., Burkhart, C., Arnheiter, H., Hengartner, H., and Zinkernagel, R. (1994) Virus or a hapten-carrier complex can activate autoreactive B cells by providing linked T help. Eur. J. Immunol. 24, 773-776.
49. Lecoeur, S., Bonierbale, E., Chaline, D., Gautier, J. C., Valadon, P., Dansette, P. M., Catinot, R., Ballet, F., Mansuy, D., and Beaune, P. H. (1994) Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem. Res. Toxicol. 7, 434-442.
50. Bourdi, M., Tinel, M., Pessayre, D., and Beaune, P. H. (1994) Metabolic activation of dihydralazine by P450IA2 and its possible implication in triggering of dihydralazine induced hepatitis. Mol. Pharmacol. 45, 1287-1295.
51. Kenna, J. G., Satoh, H., Christ, D. D., and Pohl, L. R. (1988) Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J. Pharmacol. Exp. Ther. 245, 1103-1109.
52. Bhol, K., Natarajan, K., Nagarwalla, N., Mohimen, A., Aoki, V., and Ahmed, A. R. (1995) Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc. Natl. Acad. Sci. U.S.A. 92, 5239-5243.
53. Saalman, R., Dahlgren, U. I., Fallstrom, S. P., Hanson, L. A., Wold, A. E., and Ahlstedt, S. (1995) ADCC-mediating capacity in children with cow's milk protein intolerance in relation to IgG subclass profile of serum antibodies to beta-lactoglobulin. Scand. J. Immunol. 42, 140-146.
54. Torgano, G., Vecchi, M., Podda, M., Zuin, M., Arosio, E., Battezzati, P. M., and de Franchis, R. (1995) Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulations. J. Hepatol. 22, 545-550.
55. Ando, K., Guidotti, L. G., Wirth, S., Ishikawa, T., Missale, G., Moriyama, T., Schreiber, R. D., Schlicht, H.-J., Huang, S., and Chisari, F. V. (1994) Class I-Restricted Cytotoxic T Lymphocytes are Directly Cytopathic for Their Target Cells In Vivo. J. Immunol. 152, 3245-3253.
56. Hastings, K. L., Thomas, C., Brown, A. P., and Gandolfi, A. J. (1995) Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pig. Immunopharmacol. Immunotoxicol. 17, 201-213.
57. Eliasson, E., Hume-Smith, H. V., Gardner, I., and Kenna, J. G. (1995) Cytochrome P450 2E1 and halothane hepatitis. ISSX Proc. 8, 229.